Logo image of BILL

BILL HOLDINGS INC (BILL) Stock Fundamental Analysis

USA - NYSE:BILL - US0900431000 - Common Stock

52.13 USD
-0.64 (-1.21%)
Last: 10/8/2025, 8:04:00 PM
52.07 USD
-0.06 (-0.12%)
After Hours: 10/8/2025, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BILL. BILL was compared to 281 industry peers in the Software industry. BILL has a medium profitability rating, but doesn't score so well on its financial health evaluation. BILL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BILL was profitable.
BILL had a positive operating cash flow in the past year.
BILL had negative earnings in 4 of the past 5 years.
Of the past 5 years BILL 4 years had a positive operating cash flow.
BILL Yearly Net Income VS EBIT VS OCF VS FCFBILL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

The Return On Assets of BILL (0.24%) is better than 60.14% of its industry peers.
BILL's Return On Equity of 0.61% is fine compared to the rest of the industry. BILL outperforms 62.63% of its industry peers.
Industry RankSector Rank
ROA 0.24%
ROE 0.61%
ROIC N/A
ROA(3y)-0.8%
ROA(5y)-1.52%
ROE(3y)-1.86%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
BILL Yearly ROA, ROE, ROICBILL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4 -6 -8

1.3 Margins

BILL's Profit Margin of 1.63% is fine compared to the rest of the industry. BILL outperforms 63.35% of its industry peers.
BILL has a better Gross Margin (81.40%) than 85.77% of its industry peers.
In the last couple of years the Gross Margin of BILL has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 1.63%
GM 81.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y1.61%
BILL Yearly Profit, Operating, Gross MarginsBILL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

3

2. Health

2.1 Basic Checks

BILL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BILL has been reduced compared to 1 year ago.
The number of shares outstanding for BILL has been increased compared to 5 years ago.
Compared to 1 year ago, BILL has a worse debt to assets ratio.
BILL Yearly Shares OutstandingBILL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BILL Yearly Total Debt VS Total AssetsBILL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 0.74, we must say that BILL is in the distress zone and has some risk of bankruptcy.
BILL has a Altman-Z score of 0.74. This is in the lower half of the industry: BILL underperforms 66.55% of its industry peers.
BILL has a debt to FCF ratio of 5.54. This is a neutral value as BILL would need 5.54 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.54, BILL is in line with its industry, outperforming 56.94% of the companies in the same industry.
BILL has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
BILL has a worse Debt to Equity ratio (0.43) than 62.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.54
Altman-Z 0.74
ROIC/WACCN/A
WACC10.3%
BILL Yearly LT Debt VS Equity VS FCFBILL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.58 indicates that BILL should not have too much problems paying its short term obligations.
BILL has a Current ratio of 1.58. This is comparable to the rest of the industry: BILL outperforms 51.25% of its industry peers.
A Quick Ratio of 1.58 indicates that BILL should not have too much problems paying its short term obligations.
BILL's Quick ratio of 1.58 is in line compared to the rest of the industry. BILL outperforms 51.60% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
BILL Yearly Current Assets VS Current LiabilitesBILL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

5

3. Growth

3.1 Past

The earnings per share for BILL have decreased by -5.13% in the last year.
BILL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.36%.
BILL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 56.14% yearly.
EPS 1Y (TTM)-5.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.02%
Revenue 1Y (TTM)13.36%
Revenue growth 3Y31.58%
Revenue growth 5Y56.14%
Sales Q2Q%11.55%

3.2 Future

Based on estimates for the next years, BILL will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.93% on average per year.
Based on estimates for the next years, BILL will show a quite strong growth in Revenue. The Revenue will grow by 12.67% on average per year.
EPS Next Y-1.82%
EPS Next 2Y6.24%
EPS Next 3Y13.96%
EPS Next 5Y19.93%
Revenue Next Year10.71%
Revenue Next 2Y12.25%
Revenue Next 3Y13.47%
Revenue Next 5Y12.67%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BILL Yearly Revenue VS EstimatesBILL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
BILL Yearly EPS VS EstimatesBILL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

BILL is valuated rather expensively with a Price/Earnings ratio of 23.48.
Based on the Price/Earnings ratio, BILL is valued a bit cheaper than the industry average as 73.31% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.91. BILL is around the same levels.
BILL is valuated rather expensively with a Price/Forward Earnings ratio of 23.92.
BILL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BILL is cheaper than 69.75% of the companies in the same industry.
BILL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.48
Fwd PE 23.92
BILL Price Earnings VS Forward Price EarningsBILL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BILL is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, BILL is valued cheaply inside the industry as 83.99% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.11
EV/EBITDA 388.45
BILL Per share dataBILL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as BILL's earnings are expected to grow with 13.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.24%
EPS Next 3Y13.96%

0

5. Dividend

5.1 Amount

BILL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BILL HOLDINGS INC

NYSE:BILL (10/8/2025, 8:04:00 PM)

After market: 52.07 -0.06 (-0.12%)

52.13

-0.64 (-1.21%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)10-30 2025-10-30/amc
Inst Owners96.11%
Inst Owner Change0%
Ins Owners3.42%
Ins Owner Change4.56%
Market Cap5.30B
Analysts76.77
Price Target60.1 (15.29%)
Short Float %13.54%
Short Ratio3.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.04%
Min EPS beat(2)28.01%
Max EPS beat(2)30.07%
EPS beat(4)4
Avg EPS beat(4)25.06%
Min EPS beat(4)19.52%
Max EPS beat(4)30.07%
EPS beat(8)8
Avg EPS beat(8)23.94%
EPS beat(12)12
Avg EPS beat(12)56.68%
EPS beat(16)16
Avg EPS beat(16)58.54%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)0.73%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)9
Avg Revenue beat(12)2.69%
Revenue beat(16)13
Avg Revenue beat(16)4.44%
PT rev (1m)2.41%
PT rev (3m)-5.72%
EPS NQ rev (1m)0.68%
EPS NQ rev (3m)-6.37%
EPS NY rev (1m)-1.89%
EPS NY rev (3m)-1.75%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)-1.02%
Revenue NY rev (3m)-1.56%
Valuation
Industry RankSector Rank
PE 23.48
Fwd PE 23.92
P/S 3.62
P/FCF 17.11
P/OCF 15.11
P/B 1.35
P/tB 4.09
EV/EBITDA 388.45
EPS(TTM)2.22
EY4.26%
EPS(NY)2.18
Fwd EY4.18%
FCF(TTM)3.05
FCFY5.85%
OCF(TTM)3.45
OCFY6.62%
SpS14.39
BVpS38.51
TBVpS12.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.24%
ROE 0.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.63%
GM 81.4%
FCFM 21.17%
ROA(3y)-0.8%
ROA(5y)-1.52%
ROE(3y)-1.86%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y1.61%
F-Score7
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.54
Debt/EBITDA 190.16
Cap/Depr 45.81%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion 3966.56%
Profit Quality 1301.21%
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 0.74
F-Score7
WACC10.3%
ROIC/WACCN/A
Cap/Depr(3y)32.89%
Cap/Depr(5y)61.93%
Cap/Sales(3y)2.46%
Cap/Sales(5y)3.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.02%
EPS Next Y-1.82%
EPS Next 2Y6.24%
EPS Next 3Y13.96%
EPS Next 5Y19.93%
Revenue 1Y (TTM)13.36%
Revenue growth 3Y31.58%
Revenue growth 5Y56.14%
Sales Q2Q%11.55%
Revenue Next Year10.71%
Revenue Next 2Y12.25%
Revenue Next 3Y13.47%
Revenue Next 5Y12.67%
EBIT growth 1Y45.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.34%
EBIT Next 3Y21.49%
EBIT Next 5Y37.8%
FCF growth 1Y20.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.78%
OCF growth 3YN/A
OCF growth 5YN/A